why choose us

First received: December 07, 2022

Clinical Trial: Targeting the Neurobiology of RRB in Autism Using N-acetylcysteine: Trial

Study Status: Completed

Recruit Status: RECRUITING

Condition: Autism Spectrum Disorder

Study Type: INTERVENTIONAL


Official Title: Targeting the Neurobiology of Restricted and Repetitive Behaviors in Children With Autism Using N-acetylcysteine: A Randomized, Controlled Trial

Brief Summary: The goal of this study is to target the neurobiology of restricted and repetitive behaviors in children with autism spectrum disorder using N-acetylcysteine (NAC), a well-tolerated nutritional supplement that has shown promise for reducing symptom severity in recent small-scale trials.The findings from this research will shed light on the mechanisms of action underlying the clinical benefits of NAC and the effects of NAC on altering restricted and repetitive behavior symptom severity in children with autism…

Read more